Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease

To assess plasma phosphorylated tau181 (p-tau181) as a progression biomarker in Alzheimer’s disease (AD), we examined longitudinal plasma p-tau181 of 1184 participants (403 cognitively normal (CN), 560 patients with mild cognitive impairment (MCI), and 221 with AD dementia) from Alzheimer’s Disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shi-Dong, Huang, Yu-Yuan, Shen, Xue-Ning, Guo, Yu, Tan, Lan, Dong, Qiang, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197760/
https://www.ncbi.nlm.nih.gov/pubmed/34120152
http://dx.doi.org/10.1038/s41398-021-01476-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197760/
https://www.ncbi.nlm.nih.gov/pubmed/34120152
http://dx.doi.org/10.1038/s41398-021-01476-7

Ejemplares similares